Chinese Journal of Tissue Engineering Research

Previous Articles     Next Articles

Autologous bone marrow mesenchymal stem cells and related chemokines in
fracture microenvironment

Zhang Xian-yu1, Wang Wei2, Chen Wei3, Chen Jian-mei4, Xu Hao4   

  1. 1Department of Orthopedics, People’s Hospital of Shangrao, Shangrao  334000, Jiangxi Province, China; 2Department of Pathology, Shangrao Branch of Jiangxi Medical College, Shangrao  334000, Jiangxi Province, China; 3Department of Orthopedics, the Second Hospital of Fuzhou, Fuzhou  350007, Fujian Province, China; 4Department of Orthopedics, Fuzhou General Hospital of Nanjing Military Area Command of PLA, Fuzhou  350002, Fujian Province, China
  • Received:2012-11-12 Revised:2012-12-16 Online:2013-07-02 Published:2013-07-02
  • Contact: Xu Hao, Chief physician, Professor, Master’s supervisor, Department of Orthopedics, Fuzhou General Hospital of Nanjing Military Area Command of PLA, Fuzhou 350002, Fujian Province, China xiuhao@medmail.com.cn
  • About author:Zhang Xian-yu★, Master, Attending physician, Department of Orthopedics, People’s Hospital of Shangrao, Shangrao 334000, Jiangxi Province, China 50360042@qq.com
  • Supported by:

    the Natural Science Foundation of Fujian Province, No. 2007J0110*; the Military Medicine and Health Science Foundation of China, No. 07Z037*; Medicine and Health Science Foundation of Nanjing Military Area Command of PLA During the Eleventh Five-year Plan, No. 06MA145*

Abstract:

BACKGROUND: The oriented migration of bone marrow mesenchymal stem cells may depend on the interaction between local chemotactic factors and cell surface receptors. However, which chemotactic factors may mediate the oriented migration of bone marrow mesenchymal stem cells towards the fracture site remains unclear.
OBJECTIVE: To tag autologous bone marrow mesenchymal stem cells, evaluate its role in bone healing, and detect the highly expressed factors associated with migration of bone marrow mesenchymal stem cells in the microenvironment.
METHODS: The fluorescence/chimeric C57BL/6 mouse models were established, then left shankbone fracture models were also produced. The percentages of green fluorescent protein positive cells to all cells at the fracture site and the percentage of osteoblasts differentiated from bone marrow mesenchymal stem cells to all the osteoblasts were detected at different time points. The role of bone marrow mesenchymal stem cells in the fracture repairing was evaluated. The levels of chemotactic factors protein expression at the fracture site in different time points were detected with immunohistochemistry technology.
RESULTS AND CONCLUSION: The percentage of green fluorescent protein positive cells to all cells at the fracture site was (3.011±0.911)%, (9.031±0.145)%, (12.064±0.145)% at 1, 5, 14 days postoperatively; and osteoblasts differentiated from bone marrow mesenchymal stem cells accounted for 50% of all the osteoblasts. After fracture, the stromal cell derived factor-1, colony stimulating factor, hepatocyte growth factor, monocyte chemoattractant protein-1, and matrix metalloproteinases-9 were expressed to varying degrees in the microenvironment, while the expression of granulocyte colony-stimulating factor was negative. The expression of stromal cell derived factor-1 in the fracture microenvironment was the highest, mainly due to the migration of bone marrow mesenchymal stem cells. Experimental findings indicate that, autologous bone marrow mesenchymal stem cells participate in and play an important role in bone healing. The stromal cell derived factor-1 plays an important role in promoting bone marrow mesenchymal stem cells migration and promoting bone healing.

Key words:  stem cells, bone marrow-derived stem cells, green fluorescence protein, bone marrow mesenchymal stem cells, chimera, fracture, chemokine, stromal cell derived factor-1, colony stimulating factor, hepatocyte growth factor, monocyte chemoattractant protein-1, matrix metalloproteinases-9, provincial grants-supported paper, stem cell photographs-containing paper

CLC Number: